Dabigatran Etexilate + Pretomanid Interaction
Unknowninteraction on record
Description
P-gp substrate. In vitro studies suggest pretomanid may inhibit P-gp, potentially increasing dabigatran etexilate exposure. Clinical impact unknown; monitor for adverse reactions.
Mechanism
Potential P-gp transporter inhibition
Source: NLP:pretomanid